Newton, MA, United States of America

Milka Yanachkova

This inventor holds 3 USPTO granted patents. Top assignee: Drug Innovation & Design, Inc.. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Milka Yanachkova. Retrieved from https://idiyas.com/inventor/milka-yanachkova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Milka Yanachkova: Innovator in Drug Development

Introduction

Milka Yanachkova is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of drug innovation, particularly in the development of prodrugs. With a total of 3 patents to her name, her work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Milka's latest patents include innovative formulations such as Acyclovir diester derivatives, which are novel prodrugs represented by specific structural formulas. Additionally, she has developed methods for preparing acyclovir prodrugs, further enhancing the therapeutic potential of this important antiviral medication.

Career Highlights

Milka is currently employed at Drug Innovation & Design, Inc., where she continues to push the boundaries of drug development. Her expertise in creating effective prodrugs has positioned her as a valuable asset in her field.

Collaborations

Milka has collaborated with notable colleagues, including Arnold Glazier and Ivan Yanachkov, to advance her research and development efforts. These partnerships have fostered a collaborative environment that encourages innovation.

Conclusion

Milka Yanachkova's contributions to drug innovation exemplify her dedication to improving healthcare through her inventive spirit. Her work in developing prodrugs showcases her commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…